Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02381080
Title Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

mantle cell lymphoma

marginal zone B-cell lymphoma

follicular lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Erythromycin + Ibrutinib + Voriconazole

Age Groups: adult
Covered Countries ESP | CAN


No variant requirements are available.